FAP and hepatocellular carcinoma: Subsequently, we evaluated the prognostic potential of specific markers highly expressed in each subpopulation of HCC and found that patients with higher CYRAB, FAP, and NDUFA4L2 expression had poorer OS (Figure 3I), whereas patients with lower APOC3 expression had poorer RFS (Figure 3J).